News

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.
Medical device company DexCom (NASDAQ:DXCM) will be reporting results tomorrow after market hours. Here’s what to look for. DexCom beat analysts’ revenue expectations by 0.9% last quarter ...
DexCom's estimated fair value is US$116 based on 2 Stage Free Cash Flow to Equity DexCom is estimated to be 27% undervalued based on current share price of US$84.83 The US$98.01 analyst price ...
Cheng Xin / Getty Images Shares of DexCom (DXCM) jumped more than 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose monitoring devices for people with diabetes reported ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his ...
New Product Launch: Dexcom plans to launch a 15-day G7 sensor in the second half of 2025, which is expected to bolster margins and enhance user experience. Additionally, efforts are underway to ...
DexCom (NASDAQ:DXCM) will release its earnings report on Thursday, May 1, 2025. Historically, the stock has exhibited significant volatility around its earnings announcements. Over the past five ...
Devices like Dexcom’s Stelo and Abbott’s Lingo are no longer just for people managing diabetes with a prescription – they’re now available to anyone who wants insight into how blood sugar ...
Dexcom reaffirmed its 2025 revenue guidance of $4.6 billion, representing 14% growth. The company also maintained its operating margin and adjusted EBITDA margin guidance at approximately 21% and ...
DexCom has named its chief operating officer, Jacob Leach, to the additional post of president. The San Diego medical-device company on Tuesday said Kevin Sayer, who previously held the president ...
Shares of DexCom Inc. DXCM rallied 2.87% to $86.52 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.10% to 5,892.58 and ...
Nasdaq climbed 1.24%, powered by gains in semiconductors, financials, and mid-cap tech names like Palantir and Dexcom. Dexcom jumped 15%, AppLovin rose 9.4%, and Arm added 6% as semiconductor and ...